Tizabet 200 mg (Capsule)
Unit Price: ৳ 7.02 (3 x 10: ৳ 210.60)
Strip Price: ৳ 70.20
Medicine Details
Category | Details |
---|---|
Generic | Fenofibrate |
Company | Aci limited |
Indications
- Tizabet is indicated for hyperlipidemias of type lla, llb, III, IV & V
Pharmacology
- Fenofibrate is a fibric acid derivative
- Produces reductions in total cholesterol, LDL cholesterol, Apo-lipoprotein B, Total triglycerides and VLDL
- Increases in HDL and apo-proteins apoAI apoAII
- Reduces serum uric acid levels
- Micronised form has enhanced absorption
Dosage & Administration
- Initial dose of Fenofibrate for adult patients with hypercholesterolemia or mixed hyperlipidemia is 200 mg per day
- Initial dose for adult patients with hypertriglyceridemia is 67 to 200 mg per day
- Dose should be individualized according to patient response
- Fenofibrate should be given with meal for optimizing bioavailability
Interaction
- Potentiates the anticoagulant effects of warfarin
- May improve glucose tolerance and have additive effect when administered with antidiabetic drug
- May increase the nephrotoxicity of cyclosporine
- Cautions should be taken against the use with HMG-CoA reductase inhibitors
- Low-dose statins with Tizabet appears to be well tolerated
Contraindications
- Hypersensitivity to Fenofibrate
- Severe renal or hepatic impairment
- Existing gall bladder disease
- Breast feeding mothers
- Photosensitivity to ketoprofen
Side Effects
- Gastro-intestinal issues like nausea, anorexia, gastric pain
- Pruritus, urticaria
- Impotence
- Headache, dizziness, vertigo, fatigue
- Hair loss
- Myotoxicity
Pregnancy & Lactation
- Fenofibrate is not recommended for pregnant women
Precautions & Warnings
- Special care needed in patients with renal disease
- Discontinue if myotoxicity suspected or creatinine kinase concentration increases significantly
- Liver function tests recommended every 3 months for first year
Overdose Effects
- No specific treatment for overdose
- General supportive care indicated
- Hemodialysis not considered due to high binding to plasma proteins
Therapeutic Class
- Fibrates
Storage Conditions
- Do not store above 30°C
- Keep away from light and out of the reach of children